JNJ

Q: What is the price of Johnson & Johnson (JNJ) today?

The current price of Johnson & Johnson (JNJ) is $ 240.16, representing a 59.89% gain over the past year. The stock began the year trading around $ 206.95 and is currently priced at $ 240.16. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Johnson & Johnson (JNJ) pay dividends?

In the last year, Johnson & Johnson (JNJ) distributed dividends in the month of March, totaling $ 1.30. The Dividend Yield for the last 12 months is 2.14%.

Johnson & Johnson

Price

$ 240.16

return (12m)

59.89%

p/e

21.88

p/bv

7.40

DIVIDEND YIELD

2.14%

JNJ price

JNJ

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment JNJ

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.56%

3 months

10.47%

1 year

59.89%

2 years

72.73%

5 years

70.59%

10 years

185.57%

Fundamentals JNJ

review the fundamentals of Johnson & Johnson shares

P/E

21.88

Sector: -3.96 Industry: -3.96

P/S (PSR)

6.23

Sector: -3.88 Industry: -3.88

P/BV

7.40

Sector: 1.87 Industry: 1.87

DIVIDEND YIELD (DY)

2.14%

Sector: - Industry: -

ROA

0.00%

Sector: -61.39% Industry: -61.39%

ROE

33.81%

Sector: -60.71% Industry: -60.71%

ROIC

15.05%

Sector: -1,194.93% Industry: -1,194.93%

NET MARGIN

28.46%

Sector: -39.39% Industry: -39.39%

GROSS MARGIN

67.88%

Sector: 38.09% Industry: 38.09%

OPERATING MARGIN

27.39%

Sector: -39.58% Industry: -39.58%

EV/EBITDA

15.06

Sector: -3.80 Industry: -3.80

EV/EBIT

17.53

Sector: -4.02 Industry: -4.02

PRICE-TO-ASSETS

Sector: 1.38 Industry: 1.38

BVPS

32.91

Sector: 1.89 Industry: 1.89

EPS

11.13

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

3.65%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

5.12%

Sector: - Industry: -

FAIR VALUE OF Johnson & Johnson ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 240.16

Fair Value

$ 0.00

Upside/Downside Return potential.

-62.20%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals JNJ

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
PFE	20.06	1.67	8.35%	6.28%	$ 155.85 B	12.42%
ABBV	89.02	0.00	0.00%	3.12%	$ 376.19 B	6.91%
NVO	10.61	5.46	51.50%	4.98%	$ 166.18 B	33.05%
MRK	16.72	0.00	0.00%	2.70%	$ 305.21 B	28.08%
AZN	31.27	6.56	20.99%	1.55%	$ 319.77 B	17.41%
GILD	20.77	7.81	37.62%	2.24%	$ 176.72 B	28.90%
BMY	16.98	-3.52	-20.72%	4.23%	$ 119.74 B	14.64%
ZTS	19.59	15.72	80.25%	1.70%	$ 52.37 B	28.23%
REGN	17.51	2.52	14.41%	0.47%	$ 78.86 B	31.41%
HALO	24.94	161.91	649.21%	0.00%	$ 7.90 B	22.69%
AMGN	24.97	22.24	89.06%	2.70%	$ 192.51 B	20.98%
MCK	24.84	-1,089.08	-4,383.84%	0.36%	$ 107.82 B	1.09%
VRTX	28.42	6.02	21.18%	0.00%	$ 112.36 B	32.94%
CAH	30.78	-18.95	-61.56%	0.94%	$ 51.16 B	0.68%
HRMY	10.31	1.88	18.24%	0.00%	$ 1.64 B	18.27%
ADMA	16.29	5.01	30.78%	0.00%	$ 2.39 B	28.80%
BIIB	20.21	1.43	7.08%	0.00%	$ 26.12 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

JNJ Historical Dividends

current DY: 2.14%

5-year average DY: 2.89%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/24/2026	03/10/2026	1,30000000
Dividends	11/25/2025	12/09/2025	1,30000000
Dividends	08/26/2025	09/09/2025	1,30000000
Dividends	05/27/2025	06/10/2025	1,30000000
Dividends	02/18/2025	03/04/2025	1,24000000
Dividends	11/26/2024	12/10/2024	1,24000000
Dividends	08/27/2024	09/10/2024	1,24000000
Dividends	05/21/2024	06/04/2024	1,24000000
Dividends	02/20/2024	03/05/2024	1,19000000
Dividends	11/21/2023	12/05/2023	1,19000000
Dividends	08/28/2023	09/07/2023	1,19000000
Dividends	05/23/2023	06/06/2023	1,19000000
Dividends	02/21/2023	03/07/2023	1,13000000
Dividends	11/22/2022	12/06/2022	1,13000000
Dividends	08/23/2022	09/06/2022	1,13000000
Dividends	05/24/2022	06/07/2022	1,13000000
Dividends	02/22/2022	03/08/2022	1,06000000
Dividends	11/23/2021	12/07/2021	1,06000000
Dividends	08/24/2021	09/07/2021	1,06000000
Dividends	05/25/2021	06/08/2021	1,06000000
Dividends	02/23/2021	03/09/2021	1,01000000
Dividends	11/24/2020	12/08/2020	1,01000000
Dividends	08/25/2020	09/08/2020	1,01000000
Dividends	05/26/2020	06/09/2020	1,01000000
Dividends	02/25/2020	03/10/2020	0,95000000
Dividends	11/26/2019	12/10/2019	0,95000000
Dividends	08/27/2019	09/10/2019	0,95000000
Dividends	05/28/2019	06/11/2019	0,95000000
Dividends	02/26/2019	03/12/2019	0,90000000
Dividends	11/27/2018	12/11/2018	0,90000000
Dividends	08/28/2018	09/11/2018	0,90000000
Dividends	05/29/2018	06/12/2018	0,90000000
Dividends	02/27/2018	03/13/2018	0,84000000
Dividends	11/28/2017	12/12/2017	0,84000000
Dividends	08/29/2017	09/12/2017	0,84000000
Dividends	05/30/2017	06/13/2017	0,84000000
Dividends	02/28/2017	03/14/2017	0,80000000
Dividends	11/22/2016	12/06/2016	0,80000000
Dividends	08/23/2016	09/06/2016	0,80000000
Dividends	05/24/2016	06/07/2016	0,80000000
Dividends	02/23/2016	03/08/2016	0,75000000
Dividends	11/24/2015	12/08/2015	0,75000000
Dividends	08/25/2015	09/08/2015	0,75000000
Dividends	05/26/2015	06/09/2015	0,75000000
Dividends	02/24/2015	03/10/2015	0,70000000
Dividends	11/25/2014	12/09/2014	0,70000000
Dividends	08/26/2014	09/09/2014	0,70000000
Dividends	05/27/2014	06/10/2014	0,70000000
Dividends	02/25/2014	03/11/2014	0,66000000
Dividends	11/26/2013	12/10/2013	0,66000000
Dividends	08/27/2013	09/10/2013	0,66000000
Dividends	05/28/2013	06/11/2013	0,66000000
Dividends	02/26/2013	03/12/2013	0,61000000
Dividends	11/27/2012	12/11/2012	0,61000000
Dividends	08/28/2012	09/11/2012	0,61000000
Dividends	05/29/2012	06/12/2012	0,61000000
Dividends	02/28/2012	03/13/2012	0,57000000
Dividends	11/29/2011	12/13/2011	0,57000000
Dividends	08/30/2011	09/13/2011	0,57000000
Dividends	05/31/2011	06/14/2011	0,57000000
Dividends	03/01/2011	03/15/2011	0,54000000
Dividends	11/30/2010	12/14/2010	0,54000000
Dividends	08/31/2010	09/14/2010	0,54000000
Dividends	06/01/2010	06/15/2010	0,54000000
Dividends	02/23/2010	03/09/2010	0,49000000
Dividends	11/24/2009	12/08/2009	0,49000000
Dividends	08/25/2009	09/08/2009	0,49000000
Dividends	05/26/2009	06/09/2009	0,49000000
Dividends	02/24/2009	03/10/2009	0,46000000
Dividends	11/25/2008	12/09/2008	0,46000000
Dividends	08/26/2008	09/09/2008	0,46000000
Dividends	05/27/2008	06/10/2008	0,46000000
Dividends	02/26/2008	03/11/2008	0,41500000
Dividends	11/27/2007	12/11/2007	0,41500000
Dividends	08/28/2007	09/11/2007	0,41500000
Dividends	05/29/2007	06/12/2007	0,41500000
Dividends	02/27/2007	03/13/2007	0,37500000
Dividends	11/28/2006	12/12/2006	0,37500000
Dividends	08/29/2006	09/12/2006	0,37500000
Dividends	05/30/2006	06/13/2006	0,37500000
Dividends	02/28/2006	03/14/2006	0,33000000
Dividends	11/22/2005	12/13/2005	0,33000000
Dividends	08/23/2005	09/13/2005	0,33000000
Dividends	05/17/2005	06/07/2005	0,33000000
Dividends	02/15/2005	03/08/2005	0,28500000
Dividends	11/16/2004	12/07/2004	0,28500000
Dividends	08/17/2004	09/07/2004	0,28500000
Dividends	05/18/2004	06/08/2004	0,28500000
Dividends	02/17/2004	03/09/2004	0,24000000
Dividends	11/18/2003	12/09/2003	0,24000000
Dividends	08/19/2003	09/09/2003	0,24000000
Dividends	05/20/2003	06/10/2003	0,24000000
Dividends	02/18/2003	03/11/2003	0,20500000
Dividends	11/19/2002	12/10/2002	0,20500000
Dividends	08/20/2002	09/10/2002	0,20500000
Dividends	05/21/2002	06/11/2002	0,20500000
Dividends	02/19/2002	03/12/2002	0,18000000
Dividends	11/20/2001	12/11/2001	0,18000000
Dividends	08/21/2001	09/11/2001	0,18000000
Dividends	05/22/2001	06/12/2001	0,18000000
Dividends	02/20/2001	03/13/2001	0,16000000
Dividends	11/21/2000	12/12/2000	0,16000000
Dividends	08/22/2000	09/12/2000	0,16000000
Dividends	05/23/2000	06/13/2000	0,16000000
Dividends	02/15/2000	03/07/2000	0,14000000
Dividends	11/16/1999	12/07/1999	0,14000000
Dividends	08/17/1999	09/07/1999	0,14000000
Dividends	05/18/1999	06/08/1999	0,14000000
Dividends	02/16/1999	03/09/1999	0,12500000
Dividends	11/17/1998	12/08/1998	0,12500000
Dividends	08/18/1998	09/08/1998	0,12500000
Dividends	05/19/1998	06/09/1998	0,12500000
Dividends	02/17/1998	03/10/1998	0,11000000
Dividends	11/18/1997	12/09/1997	0,11000000
Dividends	08/19/1997	09/09/1997	0,11000000
Dividends	05/20/1997	06/10/1997	0,11000000
Dividends	02/18/1997	03/11/1997	0,09500000
Dividends	11/19/1996	12/10/1996	0,09500000
Dividends	08/20/1996	09/10/1996	0,09500000
Dividends	05/21/1996	06/11/1996	0,09500000
Dividends	02/20/1996	03/12/1996	0,08250000
Dividends	11/14/1995	12/05/1995	0,08250000
Dividends	08/15/1995	09/05/1995	0,08250000
Dividends	05/16/1995	06/06/1995	0,08250000
Dividends	02/14/1995	03/07/1995	0,07250000
Dividends	11/15/1994	12/06/1994	0,07250000
Dividends	08/16/1994	09/06/1994	0,07250000
Dividends	05/17/1994	06/07/1994	0,07250000
Dividends	02/15/1994	03/08/1994	0,06500000
Dividends	11/16/1993	12/07/1993	0,06500000
Dividends	08/17/1993	09/07/1993	0,06500000
Dividends	05/18/1993	06/08/1993	0,06500000
Dividends	02/16/1993	03/09/1993	0,05750000
Dividends	11/17/1992	12/08/1992	0,05750000
Dividends	08/18/1992	09/08/1992	0,05750000
Dividends	05/19/1992	06/09/1992	0,05750000
Dividends	02/18/1992	03/10/1992	0,05000000
Dividends	11/19/1991	12/10/1991	0,05000000
Dividends	08/20/1991	09/10/1991	0,05000000
Dividends	05/21/1991	06/11/1991	0,05000000
Dividends	02/19/1991	03/12/1991	0,04250000
Dividends	11/20/1990	12/04/1990	0,04250000
Dividends	08/21/1990	09/04/1990	0,04250000
Dividends	05/22/1990	06/05/1990	0,04250000
Dividends	02/20/1990	03/06/1990	0,03620000

ABOUT Johnson & Johnson

Johnson & Johnson

Average Investor10 user rating

4.0 (2694 people)

United States

139 years

Founded: 1887

1944

Time since IPO - 82 years

132.250

Employees

Johnson & Johnson is a U.S.-based healthcare company founded in the late 19th century. It operates in the Healthcare sector, with a focus on pharmaceuticals and medical technology. Its shares are traded on the New York Stock Exchange under the ticker JNJ.

The company’s operations are currently concentrated in two core segments:

Innovative Medicine: Prescription therapies across areas such as immunology, oncology, neuroscience, cardiovascular and metabolic diseases, and pulmonary conditions.
MedTech (Medical Devices): Surgical technologies, orthopedics, cardiovascular devices, and vision-related products used in hospitals and clinical settings.

Johnson & Johnson maintains a global presence, operating in dozens of countries and marketing products worldwide. Its business model is research-driven, with consistent investment in R&D to develop new therapies and medical technologies.

The company employs a large global workforce across manufacturing facilities, research centers, and commercial operations. Strategic acquisitions and product innovation have supported its long-term position as one of the largest healthcare companies globally.

History and Development

Johnson & Johnson was founded in the late 1800s as a manufacturer of sterile surgical supplies, becoming a pioneer in standardized medical products.

Throughout the 20th century, the company expanded into pharmaceuticals and medical devices, building a diversified healthcare portfolio and strengthening its international presence.

In recent years, Johnson & Johnson completed the separation of its Consumer Health division into a standalone company, allowing it to focus on pharmaceuticals and medical technology.

The company also played a role in global public health initiatives, including vaccine development and large-scale medical innovation efforts.

Today, Johnson & Johnson remains a leading global healthcare company, centered on scientific research, advanced therapies, and medical technology solutions.

Additional Information

Johnson & Johnson (United States) is listed on the NYSE and has a market capitalization of $586.59 Billions, with shareholders equity totaling $79.28 Billions.

The company employs approximately 132.250 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Johnson & Johnson reported $94.19 Billions in revenue, generating net income of $26.80 Billions.

Key financial metrics include a P/E ratio of 21.88, a price-to-book (P/B) ratio of 7.40, and a trailing twelve-month dividend yield of 2.14%.

The company trades under the ticker JNJ.

Market cap

$ 586.59 Billions

Net worth

$ 79.28 Billions

$ 79,277,000,000.00

Assets

$ -

Total Shares Outstanding

2.41 Billions

2,409,000,000

Average Daily Trading Volume

$ 8.37 Millions

$ 8,371,393.30

Sector

Health Care

Industry

Biotechnology

JNJ

revenue by Business Segment Johnson & Johnson

Revenue by Region Johnson & Johnson

JNJ revenue and profits

Financial Results JNJ

DRAG THE FRAME TO SEE MORE DATA

JNJ cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 862.96 25,04% (12M)

P/E

24.84

0.36%

ROE

-4,383.84%

P/BV

-1,089.08

CAH - Cardinal Health

$ 214.95 61,92% (12M)

P/E

30.78

0.94%

ROE

-61.56%

P/BV

-18.95

PFE - Pfizer

$ 27.11 29,58% (12M)

P/E

20.06

6.28%

ROE

8.35%

P/BV

1.67

ABBV - AbbVie

$ 210.26 23,84% (12M)

P/E

89.02

3.12%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 119.96 58,59% (12M)

P/E

16.72

2.70%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 204.64 55,33% (12M)

P/E

31.27

1.55%

ROE

20.99%

P/BV

6.56

BMY - Bristol-Myers Squibb

$ 58.08 23,29% (12M)

P/E

16.98

4.23%

ROE

-20.72%

P/BV

-3.52

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 862.96 25,04% (12 M)

P/L

24.84

0.36%

ROE

-4,383.84%

P/VP

-1,089.08

CAH - Cardinal Health

$ 214.95 61,92% (12 M)

P/L

30.78

0.94%

ROE

-61.56%

P/VP

-18.95

PFE - Pfizer

$ 27.11 29,58% (12 M)

P/L

20.06

6.28%

ROE

8.35%

P/VP

1.67

ABBV - AbbVie

$ 210.26 23,84% (12 M)

P/L

89.02

3.12%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 119.96 58,59% (12 M)

P/L

16.72

2.70%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 204.64 55,33% (12 M)

P/L

31.27

1.55%

ROE

20.99%

P/VP

6.56

BMY - Bristol-Myers Squibb

$ 58.08 23,29% (12 M)

P/L

16.98

4.23%

ROE

-20.72%

P/VP

-3.52

Frequently Asked Questions

What is the price of Johnson & Johnson (JNJ) today?

The current price of Johnson & Johnson (JNJ) is $ 240.16, representing a 59.89% gain over the past year. The stock began the year trading around $ 206.95 and is currently priced at $ 240.16. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Johnson & Johnson (JNJ) pay dividends?

In the last year, Johnson & Johnson (JNJ) distributed dividends in the month of March, totaling $ 1.30. The Dividend Yield for the last 12 months is 2.14%.

Is Johnson & Johnson (JNJ) a good investment?

Johnson & Johnson (JNJ) is currently trading at $ 240.16 with a P/E ratio of 21.88%. This represents a 1,974% premium compared to its historical average P/E. Over the past year, the stock has gained 59.89 and paid $ 1.30 in dividends, resulting in a dividend yield of 2.14%. The total shareholder return over the same period was 59.89%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Johnson & Johnson (JNJ) stock?

You can buy Johnson & Johnson (JNJ) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol JNJ and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Johnson & Johnson (JNJ) yield today?

Over the past month, Johnson & Johnson (JNJ) has returned -0.56% — 59.89% over the past year, and 70.59% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 5.20 per share in dividends, resulting in a dividend yield of 2.14%.

If you were to purchase 100 shares of Johnson & Johnson (JNJ) today at the current price of $ 240.16 your total investment would be $ 24,016.00.

Based on historical performance, the investment would have grown to approximately:

$ 38,399.18 after 1 year
$ 40,968.89 after 5 years
$ 68,582.49 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

JNJ

Johnson & Johnson

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment JNJ

review the fundamentals of Johnson & Johnson shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 2.14%

5-year average DY: 2.89%

type

Ex - Dividend Date

payment date

value

ABOUT Johnson & Johnson

Johnson & Johnson

United States

139 years

1944

132.250

History and Development

Additional Information

PROFIT X PRICE JNJ

Financial Results JNJ

JNJ cash flow

Asset, Revenue and Profit Growth - JNJ

JNJ balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

Frequently Asked Questions